IRESS (IRE)
IRE $5.57
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Share price activity
- Last (Price)
- 5.57
- Change
- ▼ -0.06 (-1.07)
- Bid / Ask
- 5.57 - 5.58
- Volume
- 468,138
- Turnover
- 2,613,207
- Open
- 5.59
- Day Range
- 5.51 - 5.70
- VWAP
- 5.58
- Prev Close
- 5.63
- Last Trade
- 30/10 4:10pm
Key information
- Sector
- Technology
- Shares Issued
- 186,789,474
- NTA/Share
- -0.20
- Last Dividend
- 0.14
- Dividend Ex Date
- 28 AUG 2026
- Dividend Pay Date
- 28 SEP 2026
Current (AUD) · FY2025
- Revenue
- 556.32
- EBITDA
- 144.19
- Profit
- 79.26
- Earnings Per Share (EPS)
- 0.41
- Dividend Per Share (DPS)
- 0.21
- Yield %
- 4.72
- Market Cap
- 1,040.42
- Price to Earnings Ratio (P/E)
- 11.51
Estimates (AUD) · FY2027
- Revenue
- 519.40
- EBITDA
- —
- Profit
- 95.35
- Earnings Per Share (EPS)
- 0.49
- Dividend Per Share (DPS)
- 0.31
Quantitative rating
Undervalued
- Economic Moat
- Narrow
- Financial Health
- Moderate
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 23 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Five-star price 6.09 Fair value 6.89 One-star price 7.79
Morningstar Quantitative Rating as of 23 OCT 2026.
Quantitative valuation
- Fair Value
- 6.89
- Price / Fair Value
- 0.83
- Valuation
- Undervalued
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 23 OCT 2026. The slider runs from the five-star price (6.09) to the one-star price (7.79).
| Ratios |
|---|
| Currency (Price/reporting): AUD/AUD |
| Exchange Rate: 1.0000 |
| Price - closing or last bid | 5.72 |
| Price - 12 month high | 10.38 |
| Price - 12 month low | 5.04 |
| Pricing date | 22 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 0.69 |
| Market capitalization | 1,068.44 |
| 12 Month High price date | 24 NOV 2025 |
| 12 Month Low price date | 28 SEP 2026 |
| Volume - avg. trading volume for the last 3 months | 1.19 |
| Price - 1 Day % Change | 0.18% |
| Price - 13 week price percent change | -13.46% |
| Price - 26 week price percent change | -20.11% |
| Price - 5 Day % Change | 5.15% |
| Price - 52 week price percent change | -34.33% |
| Price - YTD price percent change | -32.63% |
| Price % Change Month To Date | 3.62% |
| EPS excluding extraordinary items - most recent fiscal year | 0.408 |
| EPS excluding extraordinary items - trailing 12 month | 0.487 |
| EPS Normalized - most recent fiscal year | 0.380 |
| Revenue/share - most recent fiscal year | 2.864 |
| Revenue/share - trailing 12 month | 2.605 |
| Book value per share - most recent fiscal year | 2.265 |
| Book value per share - most recent half-year | 2.281 |
| Book value (tangible) per share - most recent fiscal year | -0.200 |
| Book value (tangible) per share - most recent half-year | -0.137 |
| Cash per share - most recent fiscal year | 0.296 |
| Cash per share - most recent half-year | 0.248 |
| Cash Flow per share - most recent fiscal year | 0.313 |
| Cash Flow per share - trailing 12 month | 0.444 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 0.270 |
| EBITD per share - trailing 12 month | 0.771 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 0.426 |
| EPS Basic excluding extraordinary items - trailing 12 month | 0.505 |
| EPS including extraordinary items - most recent fiscal year | 0.426 |
| EPS including extraordinary items - trailing 12 month | 0.505 |
| Free Cash Flow per share - trailing 12 month | 0.282 |
| P/E excluding extraordinary items, most recent fiscal year | 11.75 |
| P/E Normalized, most recent fiscal year | 13.92 |
| Price to sales - most recent fiscal year | 2.20 |
| Price to Tangible Book - most fiscal year | — |
| Price to Free Cash Flow per Share - most recent fiscal year | 20.30 |
| Price to Cash Flow per share - trailing 12 month | 12.88 |
| Price to Book - most recent fiscal year | 2.51 |
| P/E excluding extraordinary items high, trailing 12 months | 20.96 |
| P/E excluding extraordinary items low, trailing 12 months | 10.54 |
| Net Debt, LFI | 126.44 |
| Net Debt, LFY | 108.76 |
| Dividend Yield - 5 Year Average | 3.11% |
| Dividend Yield - indicated annual dividend divided by closing price | 4.81% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 4.72% |
| Free Cash Flow - most recent fiscal year | 20.46 |
| LT debt/equity - most recent fiscal year | 36.14% |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 38.79% |
| LT debt/equity - most recent half-year | 38.68% |
| Total debt/total equity - most recent half-year | 40.54% |
| Free Cash Flow - trailing 12 month | 54.75 |
| Payout ratio - trailing 12 month | — |
| Revenue - most recent fiscal year | 556.32 |
| Revenue - trailing 12 month | 506.15 |
| EBITD - most recent fiscal year | 144.19 |
| EBITD - trailing 12 month | 149.80 |
| Earnings before taxes - most recent fiscal year | 109.22 |
| Earnings before taxes - trailing 12 month | 119.56 |
| Net Income available to common - most recent fiscal year | 79.26 |
| Net Income available to common - trailing 12 months | 93.95 |
| Earnings before taxes Normalized - most recent fiscal year | 83.72 |
| Net Income Available to Common, Normalized - most recent fiscal year | 73.90 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 0.41 |
| Net Profit Margin % - 1st historical fiscal year | 14.25% |
| Net Profit Margin % - trailing 12 month | 18.56% |
| Operating margin - 1st historical fiscal year | 15.79% |
| Operating margin - trailing 12 month | 19.57% |
| Pretax margin - trailing 12 month | 23.62% |
| Pretax margin - 1st historical fiscal year | 19.63% |
| Operating Margin - 5 year average | 12.24% |
| Pretax Margin - 5 year average | 8.17% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 10.32% |
| Free Operating Cash Flow/Revenue, TTM | 10.82% |
| Net Profit Margin - 5 year average | 5.59% |
| Return on average assets - most recent fiscal year | 11.43% |
| Return on average assets - trailing 12 month | 13.96% |
| Return on average equity - most recent fiscal year | 20.01% |
| Return on average equity - trailing 12 month | 22.80% |
| Return on average assets - 5 year average | 4.24% |
| Return on average equity - 5 year average | 6.61% |
| Net Income/employee - most recent fiscal year | — |
| Revenue/employee - most recent fiscal year | — |
| Revenue growth rate, 5 year | 0.50% |
| EPS growth rate, 5 year | 4.98% |
| Growth rate% - dividend, 3 year | -23.00% |
| Revenue/share (5 yr growth) | -0.52% |
| Growth rate% - Revenue, 3 year | -3.44% |
| Growth rate% - EPS, 3 year | 13.37% |
| Book value per share growth rate, 5 year | -5.97% |
| Capital Spending growth rate, 5 year | 11.40% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 2.82% |
Financial forecast (AUD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | |||||
| Estimate breakdown | ||||||||
Financials (AUD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Announcements
| DATE | TIME | HEADING | PAGES |
| Price sensitive |
Opinion
Iress (IRE) $8.72
IRE –7.23%: posted a FY25 result that showed stronger-than-expected revenue growth in continuing businesses (+6.8%) but a softer earnings after higher than expected R&D spend.
IRESS Ltd (IRE) $7.68
IRE was smacked 14.5% on Monday after reporting FY24 results that were weaker than expected and guidance for FY25 was underwhelming. Rising costs were/are the issue and this result will likely be a negative for Iress users (i.e. us) who will now be asked to pay for their inability to run the business efficiently, with price increases coming across the board.
IRESS (IRE) $7.03
IRE +14.87%: the market data platform upgraded guidance today which saw the stock hit 3-month highs. After a poor 1H result in August on slowing revenue growth and higher costs, the company went back to the drawing board with strategies to improve performance. Early signs show a vast improvement in the business as a result.
IRESS Ltd (IRE) $6.40
The trading platform business plunged over -38% in August posting new decade lows in the process after releasing its 1H23 result which showed that revenue growth had slowed and costs were higher than expected plus no interim dividend declared. IRE is currently trading on an FY23 EV/Cash EBITDA multiple of 16.5x and 22.7x if you include cloud transition costs which is simply too expensive in our opinion for a stock trying to steady a wobbly ship.
IRESS Ltd (IRE) $9.35
Platform & data provider IRE rallied +5.8% yesterday but the stock remains close to its multi-year lows. IRE has enjoyed a dominant position in the markets in which they operate however competition is increasing for both customers and also for staff, IRESS is a platform we use every day, and MM still feels it’s ripe for disruption.
Global Markets
US stocks experienced a tough session overnight on rising concerns that the Fed Funds Rate would indeed hit 5.1% next year and stay there longer than many are bargaining on. The broad-based S&P500 closed down -1.4% having managed to halve its losses in the last hour’s trade, what comes next is starting to feel like a coin toss.
IRESS Ltd (IRE) $9.60
Platform & data provider IRE bounced +2.6% yesterday but it’s hardly dented the stock’s plunge over the last 18 months – its -25% fall this year to date is actually tame compared to its declines since August 2021. IRE has enjoyed dominant positions in the markets they operate however competition is increasing for both customers and also for staff, plus they...
IRESS (IRE) $8.70
IRE -17.3%: finance software and administration company IRESS downgraded guidance today, sending the stock to 2-year lows. The company said slowing conversion of sales, as well as higher costs and negative FX movements, would weigh on segment profit, reducing guidance by 6.5% to $166-170m for the calendar year-end. Concerningly, the company only...
IRESS Ltd (IRE) $10.60
Stock market information and data provider IRE has plunged over 30% from its 2021 highs when it was “in play” and management rejected 2 bids from private equity firm EQT with the later coming in well above $15 - we cannot imagine many shareholders who held on are particularly grateful to the board. The stock isn’t overly cheap trading on an Est. PE for 2022 of over 24x but stable earnings and dividend...
Action
MM remains neutral toward IRE
MM remains neutral toward IRE
MM is neutral towards IRE
MM is neutral to bullish IRE
MM has no interest in IRE
MM is neutral to bearish IRE
MM is neutral/beaish IRE around $9.60
MM has no interest in IRE
MM likes IRE around $10.50
MM likes IRE as a situation play sub $13
Business Summary
Iress develops software for the financial-services industry, operating in multiple regions and servicing clients ranging from small retail to large institutional businesses. Its core business unit, mainly in Australia, generates most of the company's earnings and free cash flows. Iress expanded into noncore markets through acquisitions, ultimately eroding returns and margins, with free cash flows from the core business invested in the noncore businesses. Its recent strategyincludes reprioritizing growth in the core Trading and Market Data and Wealth businesses, and divesting/monetizing noncore assets. We view this renewed focus on its core business as a positive, as it will help maintain Iress' economic moat.